Febbo Phillip G. 4
4 · VERACYTE, INC. · Filed Mar 6, 2025
Insider Transaction Report
Form 4
VERACYTE, INC.VCYT
Febbo Phillip G.
Chief Scientific & Med Officer
Transactions
- Sale
Common Stock
2025-03-04$32.86/sh−4,467$146,808→ 86,110 total - Sale
Common Stock
2025-03-04$33.95/sh−3,570$121,205→ 82,540 total
Footnotes (3)
- [F1]The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 4, 2024.
- [F2]Represents weighted average sales price. Sale prices for the transactions range from $32.50 to $33.33. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
- [F3]Represents weighted average sales price. Sale prices for the transactions range from $33.56 to $34.42. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.